George Bickerstaff - 11 Aug 2023 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Reginald Seeto, as attorney-in-fact for George Bickerstaff
Issuer symbol
CDNA
Transactions as of
11 Aug 2023
Net transactions value
+$99,065
Form type
4
Filing time
11 Aug 2023, 19:47:25 UTC
Previous filing
21 Jun 2023
Next filing
16 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $26,380 +5,255 +6.5% $5.02 85,523 11 Aug 2023 Direct
transaction CDNA Common Stock Options Exercise $48,238 +9,745 +11% $4.95 95,268 11 Aug 2023 Direct
transaction CDNA Common Stock Options Exercise $24,447 +4,453 +4.7% $5.49 99,721 11 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Stock Option (right to buy) Options Exercise $0 -5,255 -100% $0.000000* 0 11 Aug 2023 Common Stock 5,255 $5.02 Direct F1
transaction CDNA Stock Option (right to buy) Options Exercise $0 -9,745 -100% $0.000000* 0 11 Aug 2023 Common Stock 9,745 $4.95 Direct F2
transaction CDNA Option to Purchase Common Stock Options Exercise $0 -4,453 -67% $0.000000 2,226 11 Aug 2023 Common Stock 4,453 $5.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares subject to the option vested on July 16, 2016 and 1/12th of the shares subject to the option vested monthly thereafter.
F2 1/12th of the shares subject to the option vested on August 1, 2016 and the shares subject to the option vested monthly thereafter through July 1, 2017.
F3 The options vested in three equal installments based upon the Company's achievement of certain performance goals.